Yahong Wang
About Yahong Wang
Yahong Wang is the Associate Director of Analytical & Bioanalytical at Bristol-Myers Squibb in Shanghai, with a Ph.D. in Bioanalytical Chemistry from The City University of New York and a BS in Chemistry from Peking University.
Current Title at Bristol-Myers Squibb
Yahong Wang currently holds the position of Associate Director, Analytical & Bioanalytical at Bristol-Myers Squibb in Shanghai. In this role, Yahong Wang is tasked with leading a team that manages stability studies for small-molecule new chemical entities to support global marketing applications. Additionally, Wang's responsibilities include recruiting, training, and supervising a multi-function team to handle various aspects of analytical testing, stability testing, pharmaceutical science, quality assurance, metrology, and other services.
Previous Role at WuXi AppTec
Prior to joining Bristol-Myers Squibb, Yahong Wang served as Senior Director of Analytical R&D at WuXi AppTec for one year (2008-2009) in Shanghai. During this period, Yahong Wang was actively involved in analytical research and development, contributing to the company's goals in this critical area.
Career at Pfizer
Yahong Wang has significant experience working at Pfizer, where Wang occupied the role of Senior Research Scientist (Analytical - Wyeth Research) from 1997 to 2003 in Pearl River, New York. In this capacity, Wang provided extensive support for pharmaceutical development and studies across various phases, from preclinical and IND to phase III and NDA.
Educational Background
Yahong Wang has an impressive educational background with a Ph.D. in Bioanalytical Chemistry from The City University of New York. Additionally, Wang holds a Bachelor of Science in Chemistry from Peking University. This combination of advanced education and specialized training has provided Wang with a robust foundation in both natural and synthetic chemistry.
Experience in Stability Studies
Yahong Wang has considerable experience managing stability studies for global dossier submissions. At Bristol-Myers Squibb, Wang leads efforts in handling stability studies of small-molecule new chemical entities, supporting global marketing applications. Wang's role involves ensuring compliance and accuracy in these critical pharmaceutical processes.